Literature DB >> 25661068

The role of FoxJ2 in the migration of human glioma cells.

Xiaojun Qiu1, Bin Ji2, Lixiang Yang3, Qingfeng Huang4, Wei Shi4, Zongmei Ding5, Xiaojuan He5, Na Ban5, Shaochen Fan5, Jianguo Zhang6, Ye Tian7.   

Abstract

Previous studies have demonstrated that FoxJ2 (forkhead box J2) is a member of Forkhead Box transcription factors and acts as an important prognostic indicator in human breast cancer. Our study aimed to assess the expression and function in human glioma. Western blot analysis and immunohistochemistry were performed in human glioma tissues. Low FoxJ2 expression was observed in 80 samples and its level was correlated with the grade of malignancy. A strongly positive correlation was observed between FoxJ2 and E-cadherin. Overexpression of FoxJ2 increased E-cadherin expression and decreased vimentin expression. The wound healing and transwell assays showed that overexpression of FoxJ2 significantly inhibited their migration in U87 cells. Consistent with this, knockdown of FoxJ2 promoted cellular motility. In a word, FoxJ2 suppressed cell migration and invasion in glioma, which might be a potential novel molecular targeted therapy for surgery and immune treatment.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  FoxJ2; Glioma; Migration; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 25661068     DOI: 10.1016/j.prp.2015.01.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.

Authors:  Takaki Hiwasa; Hao Wang; Ken-Ichiro Goto; Seiichiro Mine; Toshio Machida; Eiichi Kobayashi; Yoichi Yoshida; Akihiko Adachi; Tomoo Matsutani; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Mitoshi Kunimatsu; Ikuo Kamitsukasa; Masahiro Mori; Kazuo Sugimoto; Akiyuki Uzawa; Mayumi Muto; Satoshi Kuwabara; Yoshio Kobayashi; Mikiko Ohno; Eiichiro Nishi; Akiko Hattori; Masashi Yamamoto; Yoshiro Maezawa; Kazuki Kobayashi; Ryoichi Ishibashi; Minoru Takemoto; Koutaro Yokote; Hirotaka Takizawa; Takashi Kishimoto; Kazuyuki Matsushita; Sohei Kobayashi; Fumio Nomura; Takahiro Arasawa; Akiko Kagaya; Tetsuro Maruyama; Hisahiro Matsubara; Minako Tomiita; Shinsaku Hamanaka; Yushi Imai; Tomoo Nakagawa; Naoya Kato; Jiro Terada; Takuma Matsumura; Yusuke Katsumata; Akira Naito; Nobuhiro Tanabe; Seiichiro Sakao; Koichiro Tatsumi; Masaaki Ito; Fumiaki Shiratori; Makoto Sumazaki; Satoshi Yajima; Hideaki Shimada; Mikako Shirouzu; Shigeyuki Yokoyama; Takashi Kudo; Hirofumi Doi; Katsuro Iwase; Hiromi Ashino; Shu-Yang Li; Masaaki Kubota; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Yasuo Iwadate
Journal:  BMC Med       Date:  2021-06-09       Impact factor: 8.775

2.  The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.

Authors:  Zhongbao Zhang; Guangju Meng; Liang Wang; Yingying Ma; Zhongzheng Guan
Journal:  Mol Med Rep       Date:  2016-05-12       Impact factor: 2.952

3.  Exploration of the mechanism of colorectal cancer metastasis using microarray analysis.

Authors:  Shuo Chen; Yan Wang; Lin Zhang; Yinan Su; Mingqing Zhang; Juan Wang; Xipeng Zhang
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

4.  miR-20a/Foxj2 Axis Mediates Growth and Metastasis of Colorectal Cancer Cells as Identified by Integrated Analysis.

Authors:  Yong Qiang; Liang Feng; Gang Wang; Jian Liu; Jing Zhang; Lanlan Xiang; Chunjie Su; Songbai Zhang; Xiongwei Xie; Erlin Chen
Journal:  Med Sci Monit       Date:  2020-05-14

5.  Involvement of HECTD1 in LPS-induced astrocyte activation via σ-1R-JNK/p38-FOXJ2 axis.

Authors:  Ying Tang; Mengchun Zhou; Rongrong Huang; Ling Shen; Li Yang; Zhongqiu Zhou; Hui Ren; Ying Bai
Journal:  Cell Biosci       Date:  2021-03-30       Impact factor: 7.133

6.  Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer.

Authors:  Yong Li; Xinghua Zhu; Chunhua Liu; Qing Han; Xiaojing Chen; Yushan Liu; Yi Yin; Aiqin He; Fei Xia
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

7.  Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma.

Authors:  Ying Shan; Tao Chang; Si Shi; Mingming Tang; Lili Bao; Li Li; Bo You; Yiwen You
Journal:  Onco Targets Ther       Date:  2017-07-24       Impact factor: 4.147

8.  ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin.

Authors:  Hong Zhang; Qing-Feng Tang; Meng-Yao Sun; Chun-Yan Zhang; Jian-Yong Zhu; Yu-Li Shen; Bin Zhao; Zhi-Yi Shao; Li-Jun Zhang; Hong Zhang
Journal:  Cell Death Dis       Date:  2018-09-11       Impact factor: 8.469

9.  Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.

Authors:  Guang-Zhi Jin; Yajuan Zhang; Wen-Ming Cong; Xueyuan Wu; Xiongjun Wang; Siyang Wu; Siyao Wang; Weiping Zhou; Shengxian Yuan; Hong Gao; Guanzhen Yu; Weiwei Yang
Journal:  PLoS Biol       Date:  2018-10-18       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.